Goat Anti-Mouse IgG1 heavy chain (ab9165)
Key features and details
- Goat Anti-Mouse IgG1 heavy chain
- Host species: Goat
- Suitable for: ELISA, Immunodiffusion, Immunoelectrophoresis, WB
製品の概要
-
製品名
Goat Anti-Mouse IgG1 heavy chain
IgG1 二次抗体 製品一覧 -
由来種
Goat -
ターゲット生物種
Mouse -
特異性
The anti IgG1 only reacts with IgG1 by IEP and gel diffusion analysis when tested against each of the mouse IgG subclasses at 1 mg/ml. -
アプリケーション
適用あり: ELISA, Immunodiffusion, Immunoelectrophoresis, WBmore details -
免疫原
Goats were immunized with highly purified mouse IgG1 in Freunds adjuvant
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
バッファー
pH: 7.20 -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
The resulting antiserum was sequentially absorbed with IgG2a, IgG2b and IgG3 immunoabsorbants until it was IgG1 specific. The anti IgG1 was then immunoaffinity purified and tested for monospecificity. -
ポリ/モノ
ポリクローナル -
研究分野
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab9165の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ELISA |
Use at an assay dependent concentration.
|
|
Immunodiffusion |
Use at an assay dependent concentration.
|
|
Immunoelectrophoresis |
Use at an assay dependent concentration.
|
|
WB |
Use at an assay dependent concentration.
|
特記事項 |
---|
ELISA
Use at an assay dependent concentration. |
Immunodiffusion
Use at an assay dependent concentration. |
Immunoelectrophoresis
Use at an assay dependent concentration. |
WB
Use at an assay dependent concentration. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
参考文献 (2)
ab9165 は 2 報の論文で使用されています。
- Fradkin AH et al. UV photodegradation of murine growth hormone: Chemical analysis and immunogenicity consequences. Eur J Pharm Biopharm N/A:N/A (2014). PubMed: 24758742
- Fradkin AH et al. Glass particles as an adjuvant: a model for adverse immunogenicity of therapeutic proteins. J Pharm Sci 100:4953-64 (2011). PubMed: 21721003